|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR
Yury Monczak,
Michel Trudel,
William W. Lamph, and
Wilson H. Miller Jr
From the Lady Davis Institute for Medical Research, the Department of Pathology, Sir Mortimer B. Davis Jewish General Hospital and McGill University Departments of Experimental Medicine, Oncology, and Medicine, Montreal, Quebec, Canada; and Ligand Pharmaceuticals Inc, San Diego, CA.
Retinoic acid (RA) induces differentiation, followed by apoptosis in acute promyelocytic leukemia (APL) cells, both in vitro and in patients. One problem in understanding these mechanisms is to distinguish molecular events leading to differentiation from those leading to apoptosis. We have identified a leukemic cell line, PLB-985, where RA directly induces apoptosis with no morphologic, genetic, or cell-surface marker evidence of differentiation. These cells differentiate following dimethyl sulfoxide (DMSO), but not RA, treatment. Two-color flow cytometry showed no alteration of the cell cycle after RA treatment, and cell-surface marker analysis of CD11a, CD11b, and CD13 showed no modulation typical of differentiating cells. RNA expression of myeloblastin and transglutaminase, genes regulated by RA-induced differentiation in NB4 cells, was unchanged by RA treatment. Instead, RA induced apoptosis, as shown by typical apoptotic morphological features, genomic DNA laddering, and positive labeling in the TUNEL assay. We found that induction of apoptosis in this model requires a different pattern of retinoid receptor binding and transcriptional activation than is seen in APL cells. As previously described, treatment with retinoid receptor-selective ligands showed that stimulation of RAR alone is sufficient to induce differentiation and apoptosis in NB4 cells, and that stimulation of RXR has no effect on the parameters analyzed. In PLB-985 cells, on the other hand, apoptosis was induced only upon costimulation of both RAR and RXR. Stimulation of either receptor alone had no effect on the cells. Consistent with these findings, bcl-2 RNA and protein levels were downregulated after stimulation of both RAR and RXR, but not with an RAR-specific ligand alone, as in NB4 cells. The expression of several other bcl-2 family members (bcl-X, ich-1, bax, bag, and bak ) and retinoid receptors (RAR , RXR, and RXR ) was not affected by treatment with RAR- and/or RXR-activating retinoids; RAR RNA was undetectable before and after retinoid treatment. Thus, our cell model provides a useful tool in determining the genetic events mediating apoptosis as a response to RA, unobscured by events implicated in differentiation.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3345-3355
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LXIII. Retinoid X Receptors
Pharmacol. Rev.,
December 1, 2006;
58(4):
760 - 772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Yu, J. Han, J. Lin, Y. Xiao, X. Zhang, and Y. Li
Apoptosis Induced by atRA in MEPM Cells Is Mediated through Activation of Caspase and RAR
Toxicol. Sci.,
February 1, 2006;
89(2):
504 - 509.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. R. Benoit, M. Flexor, F. Besancon, L. Altucci, A. Rossin, J. Hillion, Z. Balajthy, L. Legres, E. Segal-Bendirdjian, H. Gronemeyer, et al.
Autonomous Rexinoid Death Signaling Is Suppressed by Converging Signaling Pathways in Immature Leukemia Cells
Mol. Endocrinol.,
July 1, 2001;
15(7):
1154 - 1169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Claudel, M. D. Leibowitz, C. Fiévet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al.
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
PNAS,
February 15, 2001;
(2001)
41609298.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. E. Bijwaard, N. S.I. Aguilera, Y. Monczak, M. Trudel, J. K. Taubenberger, and J. H. Lichy
Quantitative Real-Time Reverse Transcription-PCR Assay for Cyclin D1 Expression: Utility in the Diagnosis of Mantle Cell Lymphoma
Clin. Chem.,
February 1, 2001;
47(2):
195 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Konta, Q. Xu, A. Furusu, K. Nakayama, and M. Kitamura
Selective Roles of Retinoic Acid Receptor and Retinoid X Receptor in the Suppression of Apoptosis by All-trans-retinoic Acid
J. Biol. Chem.,
April 13, 2001;
276(16):
12697 - 12701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Claudel, M. D. Leibowitz, C. Fievet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al.
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
PNAS,
February 27, 2001;
98(5):
2610 - 2615.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
